MoneyWorks4Me

Glenmark Life Sciences informs about board meeting

08 Nov 2021 Evaluate
Glenmark Life Sciences has informed that the Board of Directors of the Company at its meeting scheduled to be held on Wednesday, November 10, 2021 will also consider proposal for payment of interim Dividend to members of the Company for the Financial year 2021-22.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1842.10
Dr. Reddys Labs. 1225.00
Cipla 1389.85
Lupin 2069.50
Zydus Lifesciences 1216.50
View more..